“Long-Term Proactive Management of Psoriasis Vulgaris with Fixed-Dose Combination of Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam: Results from a Phase III Randomized Controlled Trial”, J of Skin, vol. 4, no. 5, p. s32, Sep. 2020, doi: 10.25251/skin.4.supp.32.